Check Out What Whales Are Doing With PFE

Investors with a lot of money to spend have taken a bullish stance on Pfizer PFE.

And retail traders should know.

We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.

Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with PFE, it often means somebody knows something is about to happen.

So how do we know what these investors just did?

Today, Benzinga's options scanner spotted 9 uncommon options trades for Pfizer.

This isn't normal.

The overall sentiment of these big-money traders is split between 77% bullish and 22%, bearish.

Out of all of the special options we uncovered, 3 are puts, for a total amount of $308,895, and 6 are calls, for a total amount of $366,349.

What's The Price Target?

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $29.0 to $80.0 for Pfizer over the recent three months.

Volume & Open Interest Development

Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Pfizer's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Pfizer's substantial trades, within a strike price spectrum from $29.0 to $80.0 over the preceding 30 days.

Pfizer Option Activity Analysis: Last 30 Days

Significant Options Trades Detected:

About Pfizer

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

Having examined the options trading patterns of Pfizer, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance

Where Is Pfizer Standing Right Now?

• Trading volume stands at 6,127,968, with PFE's price up by 0.08%, positioned at $29.73.
• RSI indicators show the stock to be may be approaching overbought.
• Earnings announcement expected in 11 days.

What The Experts Say On Pfizer

A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $42.0.

• An analyst from Barclays persists with their Equal-Weight rating on Pfizer, maintaining a target price of $30.
• Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $45.
• An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $45.
• Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $45.
• In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $45.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Pfizer, Benzinga Pro gives you real-time options trades alerts.